Buprenorphine: Considerations for Pain Management
- 1 March 2005
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 29 (3), 297-326
- https://doi.org/10.1016/j.jpainsymman.2004.07.005
Abstract
No abstract availableKeywords
Funding Information
- Purdue Pharma
This publication has 179 references indexed in Scilit:
- Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomesLife Sciences, 1997
- Addiction in the treatment of pain: Significance, recognition, and managementJournal of Pain and Symptom Management, 1993
- Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: A pilot studyAnnals of Emergency Medicine, 1993
- Antagonism of acute cocaine toxicity by buprenorphineLife Sciences, 1991
- The Use of Buprenorphine and Temazepam by Drug InjectorsJournal of Addictive Diseases, 1991
- Opioid Agonist-Antagonist Drugs in Acute and Chronic Pain StatesDrugs, 1991
- Sublingual buprenorphine as postoperative analgesic: a double‐blind comparison with pethidineActa Anaesthesiologica Scandinavica, 1990
- Stability of the 6,14-Endo-Ethanotetrahydrooripavine Analgesics: Acid-Catalyzed Rearrangement of BuprenorphineJournal of Pharmaceutical Sciences, 1984
- Buprenorphine: Characteristics of binding sites in the rat central nervous systemLife Sciences, 1981
- BuprenorphineDrugs, 1979